Skip to main content

96 percent of the world’s genetic data is from white people — here’s how we change that

Genuinely paradigm-shifting achievements don’t come along every day, year or, heck — even every decade.

The Human Genome Project, however, was one notable exception to that rule. Decoding the genome in the early-2000s was a game changer. It wasn’t as immediately wondrous as the Moon landing, or as immediately fearsome as the atomic bomb, but it hinted at the promise of an amazing future: one in which a person’s genetic predisposition to disease could be unravelled early enough for them to act. Genome scanning would move us from a world of reactive medicine to one of proactive medicine; forever banishing the one-size-fits-all approach.

Recommended Videos

“60 percent of the world’s population comprises less than one percent of the world’s genomic data”

Jump forward around a decade-and-a-half and that dream is still becoming a reality, but it’s a slow process.

“The technology is ready,” Sumit Jamuar told Digital Trends. “It’s better, faster, cheaper, whether you look at frameworks or sequencing. But the data is missing.”

Jamuar is the co-founder and CEO of a genetics company called Global Gene Corp., whose R&D center is located in Cambridge, England. The startup’s mission? To democratize genomics research by making it available to people throughout the world.

“One statistic which staggered me when we first looked at the data is that 60 percent of the world’s population comprises less than one percent of the world’s genomic data,” Jamuar said. “There are more than 3 billion people who do not contribute sufficient genomic data. To deliver any precision medicine programs in these countries means that pharmaceutical and medical companies need to have that data. This isn’t just looking at the top 1 million or 10 million people; if we have done our job correctly we will have a real impact on a significant population set of 3 billion people of different ethnicities all around the world. To me, that is the meaning of democratizing a technology.”

Image used with permission by copyright holder

The caucasian-centric genomics data that presently makes up the bulk of available data isn’t a conspiracy. The funding for the Human Genome Project came from the United States and United Kingdom, both of which have predominantly white populations. Developing nations like India and Africa, meanwhile, have lagged behind in this research — although interest is growing.

“Many of these other governments already have their budgets stretched by fighting communicable diseases and other elements which are a priority in the immediate term,” he continued. “The good news is that as these communicable diseases are eradicated — such as India being made polio free — you can focus on the bigger threats. These are the non communicable diseases, like heart disease, cancer and the like. Those inherently have genetic codes.”

“There are more than 3 billion people who do not contribute sufficient genomic data”

Diversity in genomic data is hugely important. For instance, Indians frequently suffer from diabetes in greater proportional numbers than Westerners. The same is true with colon cancer among young people, which is at higher levels in India than in America, although just 0.2 percent of available genomic data comes from India — which holds 20 percent of the world’s population. Indian populations who suffer from colon cancer additionally show different genetic mutations from patients in Western countries. Being able to analyze genomics data for populations outside of predominantly caucasian ones means that a great degree of understanding of these issues can be gathered. It also means personalized medical treatments can be made more effective in the process.

Global Gene Corp. is working with hospitals, research organizations and individuals to gather its genomics information. It is also striving to bring the price point down to levels that are achievable in developing nations with much lower median earnings. The goal is then to use cutting-edge machine learning tools to help make sense of the data, and to draw useful correlations.

Image used with permission by copyright holder

This is where Jamuar said the value will come. He draws a parallel between personal computing in the 1980s, when it was just starting to develop the “killer apps” which made it useful to everyday consumers, and genomics-based healthcare in 2017.

Far from just a “nice to have” luxury, Jamuar pointed out that investment in this area can help cut down on wasting expensive drugs, which may prove ineffective fighting certain diseases. “The world is spending about $200 billion on cancer drugs, where you can estimate ¾ are not effective,” he said. “The same is true with many asthma drugs.”

It’s all part of a broader shift he sees taking place in which the world moves toward personalized healthcare.

“Right now, we have a symptom and we go to the doctor with it,” he said. “We then get an intervention, which could take the form of a drug which may or may not work. Twenty years from now I think that people will look back and say, ‘that’s so medieval. I can’t believe you ever used that kind of hit-and-miss experimentation.’ What will instead happen is that we’ll have data for every individual and that will give us the ability to predict the best way to avoid disease on a personal basis. It also opens up the possibility of using gene editing, where you can fix certain mutations in a person’s genetic sequence. It will be possible to do tailored treatment for every individual.”

Certainly it’s an ambitious mission, and one that will require considerable private and public funding, but it’s a crucial next step to take as genomics research continues.

Luke Dormehl
Former Digital Trends Contributor
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Star Wars legend Ian McDiarmid gets questions about the Emperor’s sex life
Ian McDiarmid as the Emperor in Star Wars: The Rise of Skywalker.

This weekend, the Star Wars: Revenge of the Sith 20th anniversary re-release had a much stronger performance than expected with $25 million and a second-place finish behind Sinners. Revenge of the Sith was the culmination of plans by Chancellor Palpatine (Ian McDiarmid) that led to the fall of the Jedi and his own ascension to emperor. Because McDiarmid's Emperor died in his first appearance -- 1983's Return of the Jedi -- Revenge of the Sith was supposed to be his live-action swan song. However, Palpatine's return in Star Wars: Episode IX -- The Rise of Skywalker left McDiarmid being asked questions about his character's comeback, particularly about his sex life and how he could have a granddaughter.

While speaking with Variety, McDiarmid noted that fans have asked him "slightly embarrassing questions" about Palpatine including "'Does this evil monster ever have sex?'"

Read more
Waymo and Toyota explore personally owned self-driving cars
Front three quarter view of the 2023 Toyota bZ4X.

Waymo and Toyota have announced they’re exploring a strategic collaboration—and one of the most exciting possibilities on the table is bringing fully-automated driving technology to personally owned vehicles.
Alphabet-owned Waymo has made its name with its robotaxi service, the only one currently operating in the U.S. Its vehicles, including Jaguars and Hyundai Ioniq 5s, have logged tens of millions of autonomous miles on the streets of San Francisco, Los Angeles, Phoenix, and Austin.
But shifting to personally owned self-driving cars is a much more complex challenge.
While safety regulations are expected to loosen under the Trump administration, the National Highway Traffic Safety Administration (NHTSA) has so far taken a cautious approach to the deployment of fully autonomous vehicles. General Motors-backed Cruise robotaxi was forced to suspend operations in 2023 following a fatal collision.
While the partnership with Toyota is still in the early stages, Waymo says it will initially study how to merge its autonomous systems with the Japanese automaker’s consumer vehicle platforms.
In a recent call with analysts, Alphabet CEO Sundar Pichai signaled that Waymo is seriously considering expanding beyond ride-hailing fleets and into personal ownership. While nothing is confirmed, the partnership with Toyota adds credibility—and manufacturing muscle—to that vision.
Toyota brings decades of safety innovation to the table, including its widely adopted Toyota Safety Sense technology. Through its software division, Woven by Toyota, the company is also pushing into next-generation vehicle platforms. With Waymo, Toyota is now also looking at how automation can evolve beyond assisted driving and into full autonomy for individual drivers.
This move also turns up the heat on Tesla, which has long promised fully self-driving vehicles for consumers. While Tesla continues to refine its Full Self-Driving (FSD) software, it remains supervised and hasn’t yet delivered on full autonomy. CEO Elon Musk is promising to launch some of its first robotaxis in Austin in June.
When it comes to self-driving cars, Waymo and Tesla are taking very different roads. Tesla aims to deliver affordability and scale with its camera, AI-based software. Waymo, by contrast, uses a more expensive technology relying on pre-mapped roads, sensors, cameras, radar and lidar (a laser-light radar), that regulators have been quicker to trust.

Read more
Uber partners with May Mobility to bring thousands of autonomous vehicles to U.S. streets
uber may mobility av rides partnership

The self-driving race is shifting into high gear, and Uber just added more horsepower. In a new multi-year partnership, Uber and autonomous vehicle (AV) company May Mobility will begin rolling out driverless rides in Arlington, Texas by the end of 2025—with thousands more vehicles planned across the U.S. in the coming years.
Uber has already taken serious steps towards making autonomous ride-hailing a mainstream option. The company already works with Waymo, whose robotaxis are live in multiple cities, and now it’s welcoming May Mobility’s hybrid-electric Toyota Sienna vans to its platform. The vehicles will launch with safety drivers at first but are expected to go fully autonomous as deployments mature.
May Mobility isn’t new to this game. Backed by Toyota, BMW, and other major players, it’s been running AV services in geofenced areas since 2021. Its AI-powered Multi-Policy Decision Making (MPDM) tech allows it to react quickly and safely to unpredictable real-world conditions—something that’s helped it earn trust in city partnerships across the U.S. and Japan.
This expansion into ride-hailing is part of a broader industry trend. Waymo, widely seen as the current AV frontrunner, continues scaling its service in cities like Phoenix and Austin. Tesla, meanwhile, is preparing to launch its first robotaxis in Austin this June, with a small fleet of Model Ys powered by its camera-based Full Self-Driving (FSD) system. While Tesla aims for affordability and scale, Waymo and May are focused on safety-first deployments using sensor-rich systems, including lidar—a tech stack regulators have so far favored.
Beyond ride-hailing, the idea of personally owned self-driving cars is also gaining traction. Waymo and Toyota recently announced they’re exploring how to bring full autonomy to private vehicles, a move that could eventually bring robotaxi tech right into your garage.
With big names like Uber, Tesla, Waymo, and now May Mobility in the mix, the ride-hailing industry is evolving fast—and the road ahead looks increasingly driver-optional.

Read more